• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human F-box/SPRY domain-containing protein 1 (FBXO45)

ACP24438

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP24438 Target NameFBXO45
Target SynonymsF box protein 45; F-box only protein 45; F-box/SPRY domain-containing protein 1; FBSP1_HUMAN; FBX45; fbxo45; hFbxo45FormLyophilized powder
Expression SystemCustom Production. Please inquire and provide the desire expression system.Expression Range2-286
Protein LengthFull Length of Mature ProteinPurity>85% (SDS-PAGE)
Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDP0C2W1
Background Information
  • Uniprot Id

    P0C2W1

  • Target Species

    Human

  • Target Name

    FBXO45

  • Target Full Name

    F-box/SPRY domain-containing protein 1

  • Target Function

    Component of E3 ubiquitin ligase complexes. Required for normal neuromuscular synaptogenesis, axon pathfinding and neuronal migration. Plays a role in the regulation of neurotransmission at mature neurons. May control synaptic activity by controlling UNC13A via ubiquitin dependent pathway. Specifically recognizes TP73, promoting its ubiquitination and degradation.

  • Target Subcellular Location

    Cell junction, synapse, postsynaptic cell membrane. Cell junction, synapse, presynaptic cell membrane.

  • Target Protein Families

    FBXO45/Fsn family

  • Target Synonyms

    F box protein 45; F-box only protein 45; F-box/SPRY domain-containing protein 1; FBSP1_HUMAN; FBX45; fbxo45; hFbxo45

Inquire Recombinant Human F-box/SPRY domain-containing protein 1 (FBXO45) Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification